Venture Capital
London, England, W1B 5AW
4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764). 4BIO Partners LLP is an SEC Registered Investment Advisor number 801-121342. 4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors; in total, they have published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine.
091424sbs
